You just read:

Daiichi Sankyo to Present at ESMO 2016 Late-Breaking Clinical Data for Novel HER2-Targeting Antibody Drug Conjugate in T-DM1 Pre-Treated Breast Cancer

News provided by

Daiichi Sankyo Company, Limited

Sep 27, 2016, 08:00 ET